METHYL 4-[(2-METHOXY-2-OXOETHYL)SULFANYL]-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDRO-3-PYRIDAZINECARBOXYLATE

METHYL 4-[(2-METHOXY-2-OXOETHYL)SULFANYL]-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDRO-3-PYRIDAZINECARBOXYLATE Struktur
338396-09-1
CAS-Nr.
338396-09-1
Englisch Name:
METHYL 4-[(2-METHOXY-2-OXOETHYL)SULFANYL]-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDRO-3-PYRIDAZINECARBOXYLATE
Synonyma:
methyl 4-[(2-methoxy-2-oxoethyl)sulfanyl]-1-(4-methoxyphenyl)-6-oxo-1,6-dihydropyridazine-3-carboxylate;METHYL 4-[(2-METHOXY-2-OXOETHYL)SULFANYL]-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDRO-3-PYRIDAZINECARBOXYLATE;3-Pyridazinecarboxylic acid, 1,6-dihydro-4-[(2-methoxy-2-oxoethyl)thio]-1-(4-methoxyphenyl)-6-oxo-, methyl ester
CBNumber:
CB0670111
Summenformel:
C16H16N2O6S
Molgewicht:
364.37
MOL-Datei:
Mol file

METHYL 4-[(2-METHOXY-2-OXOETHYL)SULFANYL]-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDRO-3-PYRIDAZINECARBOXYLATE Eigenschaften

Sicherheit

METHYL 4-[(2-METHOXY-2-OXOETHYL)SULFANYL]-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDRO-3-PYRIDAZINECARBOXYLATE Chemische Eigenschaften,Einsatz,Produktion Methoden

METHYL 4-[(2-METHOXY-2-OXOETHYL)SULFANYL]-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDRO-3-PYRIDAZINECARBOXYLATE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


METHYL 4-[(2-METHOXY-2-OXOETHYL)SULFANYL]-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDRO-3-PYRIDAZINECARBOXYLATE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Key Organics Ltd. --
info@keyorganics.net United Kingdom 6742 50
Key Organics Limited/Bionet Research --
enquiries@keyorganics.ltd.uk United Kingdom 6667 50

  • METHYL 4-[(2-METHOXY-2-OXOETHYL)SULFANYL]-1-(4-METHOXYPHENYL)-6-OXO-1,6-DIHYDRO-3-PYRIDAZINECARBOXYLATE
  • methyl 4-[(2-methoxy-2-oxoethyl)sulfanyl]-1-(4-methoxyphenyl)-6-oxo-1,6-dihydropyridazine-3-carboxylate
  • 3-Pyridazinecarboxylic acid, 1,6-dihydro-4-[(2-methoxy-2-oxoethyl)thio]-1-(4-methoxyphenyl)-6-oxo-, methyl ester
  • 338396-09-1
Copyright 2019 © ChemicalBook. All rights reserved